Overview

The Effects of Dexmedetomidine on Postoperative Renal Function in Valvular Heart Surgery

Status:
Unknown status
Trial end date:
2015-05-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of study is to compare the incidence of acute kidney injury in patients receiving perioperative dexmedetomidine or placebo undergoing valvular heart surgery.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Yonsei University
Treatments:
Dexmedetomidine
Criteria
Inclusion Criteria:

- adult patients over the age of 20 scheduled for valvular heart surgery

Exclusion Criteria:

- Left ventricular-ejection fraction < 30%

- Preexisting congestive heart failure

- Severe coronary artery disease

- Hemodynamically unstable arrhythmia

- Cardiogenic shock during perioperative period

- Ventricular assist device

- Severe renal dysfunction (eGFR < 15ml/min per 1.73m2)